Shopify (NYSE: SHOP) stock was trending during intra-day trading on Thursday, with over 2.87 million shares changing hands. The high-volume sell-off was spurred by bearish outlook given by research firm Citron on the stock.
Setting the 12-month price target on the stock at $100, Citron said it sees “drastic changes” in Shopify’s competitive landscape, which could hinder the company’s growth prospects.
The research firm was referring to reports that bigger tech firms including Microsoft (MSFT) or Facebook (FB) could soon be bringing out similar services, which in turn would eat into Shopify’s market share.
The short recommendation sent SHOP shares down over 6%. In the trailing 52 weeks period, the stock has gained 61%.
READ: LYFT AND SIX OTHER COMPANIES WENT PUBLIC IN MARCH. FULL LIST
This is the second time in the past three years that SHOP shares have suffered due to caution from Citron. The first stock plummet happened in the rear half of 2017. However, the stock rebounded soon after, thanks to the confidence of institutional investors including BNY Mellon, T. Rowe Price, and Fidelity Investments.
Investors have recently been worried about the deceleration in Shopify’s top line. In February, despite reporting market-beating fourth-quarter results, shares of Shopify (SHOP) fell over 6%, on the same reason.
Revenue for the quarter jumped 54% to $343.9 million, beating the market consensus. But the 54% increase in Q4 revenue marks the fourth consecutive quarter of growth rate decline. Revenue growth has consistently declined in the past three quarters, registering at 68% in Q1, 62% in Q2 and 58% in Q3.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on